Tazobactam
Active pharmaceutical substance formulated in Jan Aushadhi generic products for Antibiotics & Anti-Infectives treatment.
🧴 Clinical Application
Administered by a trained nurse or physician via slow IV infusion over 30 minutes after aseptic reconstitution with Water for Injections. Incompatible with calcium-containing solutions. Administer once or twice daily based on clinical severity.
⚠️ Side Effects
Common: Diarrhea, nausea, local infusion site phlebitis, rash, elevated transaminases. Rare/Severe: Anaphylaxis, Clostridioides difficile colitis, hemolytic anemia, and gallbladder sludging.
🛡️ Safety Warnings
Contraindicated in neonates receiving IV calcium. Contraindicated in cephalosporin allergy. Exercise caution in patients with hepatic and renal dysfunction simultaneously.
Jan Aushadhi Products containing Tazobactam
Found 3 generic formulation(s) containing this active ingredient.
Ceftriaxone 1g + Tazobactam 125mg Injection
Ceftriaxone Sodium and Tazobactam Sodium combines an extended-spectrum third-generation cephalosporin with the potent beta-lactamase inhibitor tazobactam. Tazobactam prevents ceftriaxone hydrolysis by plasmid- and chromosome-mediated beta-lactamases, restoring full bactericidal activity. Indicated for severe polymicrobial infections, meningitis, sepsis, complicated skin/soft tissue infections, and hospital-acquired lower respiratory infections.
Ceftriaxone 250mg + Tazobactam 31.25mg Injection
Ceftriaxone Sodium and Tazobactam Sodium combines an extended-spectrum third-generation cephalosporin with the potent beta-lactamase inhibitor tazobactam. Tazobactam prevents ceftriaxone hydrolysis by plasmid- and chromosome-mediated beta-lactamases, restoring full bactericidal activity. Indicated for severe polymicrobial infections, meningitis, sepsis, complicated skin/soft tissue infections, and hospital-acquired lower respiratory infections.
Cefepime 1000Mg + Tazobactam 125Mg Injection
Cefepime and Tazobactam is an advanced parenteral combination of a fourth-generation cephalosporin and a beta-lactamase inhibitor. Cefepime penetrates the outer bacterial membrane rapidly and possesses low affinity for AmpC beta-lactamases, while tazobactam neutralizes extended-spectrum beta-lactamases (ESBLs). Indicated for severe nosocomial pneumonia, febrile neutropenia, complicated intra-abdominal infections, and multi-drug resistant urinary sepsis.
Brand Equivalents & Price Comparison
Compare Jan Aushadhi generic prices against popular commercial brands for Tazobactam.
| Generic Formulation | Pack Size | Jan Aushadhi Price | Commercial Brand Equivalents | Avg. Commercial Price | Savings |
|---|---|---|---|---|---|
| Ceftriaxone 1g + Tazobactam 125mg Injection | Vial & Wfi | ₹45.00 | MONTAZ, XONE XP | ₹212.43 | 79% Save |
| Ceftriaxone 250mg + Tazobactam 31.25mg Injection | 1 Vial & wfi | ₹22.50 | T CEF | ₹64.80 | 65% Save |
| Cefepime 1000Mg + Tazobactam 125Mg Injection | 1.0 Injection in 1 vial | ₹150.00 | MAGNOVA, ACTAMASE, TEXAPIME | ₹370.56 | 60% Save |
Frequently Asked Questions (FAQ)
Get answers to common queries about Tazobactam generics.